Transcranial Direct Current Simulation in Chronic Migraine

Federal University of Paraíba15 enrolled

Overview

This study is a pilot, double-blind, placebo-controlled, randomized trial aiming to compare the effects of transcranial direct current stimulation in Chronic Migraine.

The patients will be randomized into 1 of 3 groups: active tDCS over primary motor cortex, active tDCS over prefrontal cortex, sham tDCS. Each group will receive treatment for 20 minutes a day, 3 days a week for 4 weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Migraine Disorders

Interventions

TDCSDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with a clinical diagnosis of chronic migraine according to the International Classification of Headaches Disorders (ICHD-3 beta) of the International Headache Society, with an established headache history occurring on 15 or more days per month-however, for at least 1 year, instead of only 3 months, as defined in the International Headache Society (IHS) guidelines. Exclusion Criteria: * headache attributable to some pathological condition, associated neurologic or neuropsychiatric disease, use of central nervous system modulating drugs, pregnancy, metallic head implants, and use of a cardiac pacemaker.

Locations (1)

Suellen Andrade

João Pessoa, Paraíba, Brazil

RECRUITING

Outcomes

Primary Outcomes

Change in quality of life associate to migraine assessed on the Headache Impact Test-6 (HIT-6)

Time frame: Baseline (week 1) and Endpoint (week 4)

Secondary Outcomes

Change in pain assessed on the Visual Analogue Scale (VAS)

Time frame: Baseline (week 1) and Endpoint (week 4)

Change in quality of life assessed on the Medical Outcomes Study 36 - Item Short - Form Health Survey(SF-36)

Time frame: Baseline (week 1) and and Endpoint (week 4)

Side Effects Questionnaire

Time frame: From date of first neurostimulation until the date of last neurostimulation, , assessed up to 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.